# FDA Inspection 1032329 - Noramco, Inc. - November 17, 2017

Source: https://www.keypedia.com/records/fda_inspections/noramco-inc/4ef67c18-a741-41c8-9afc-139e542d2a41
Source feed: FDA_Inspections

> FDA Inspection 1032329 for Noramco, Inc. on November 17, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1032329
- Company Name: Noramco, Inc.
- Inspection Date: 2017-11-17
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1287192 - 2025-10-15](https://www.keypedia.com/records/fda_inspections/noramco-inc/fc00164b-b83c-4ff4-922c-8e4d3e433955)
- [FDA Inspection 1287192 - 2025-10-15](https://www.keypedia.com/records/fda_inspections/noramco-inc/8a6fdfc5-5998-4db4-b98c-4692f75c188f)
- [FDA Inspection 1194573 - 2022-11-18](https://www.keypedia.com/records/fda_inspections/noramco-inc/6d292cd3-11e8-406a-80be-ccc0f8985f27)
- [FDA Inspection 1083841 - 2019-02-21](https://www.keypedia.com/records/fda_inspections/noramco-inc/1013f371-45c1-4788-bb33-0814a64a3368)
- [FDA Inspection 956500 - 2016-01-21](https://www.keypedia.com/records/fda_inspections/noramco-inc/9b735f17-3580-4603-939a-55129666f26d)

Company: https://www.keypedia.com/companies/noramco-inc/8af3944b-5c06-49e7-813b-71cf3dd72be6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c